For every 1,000 people in Kentucky, roughly 21 were prescribed a drug that belongs to a buzzy class of diabetes and anti-obesity medications last year the highest rate of any state, according to insurance claims data provided to Axios by health analytics company PurpleLab
What Employers Need to Know About GLP-1s What are GLP-1 Agonists
Your provider considers your health profile, weight loss goals, budget, and preferences when recommending treatment
This isnt an effective dose, but its necessary to start here if you want to minimize any side effects you may experience
The Case for Direct Switch For patients who are well-tolerating semaglutide and switching primarily for efficacy, a direct switch on the next injection date is the most common clinical practice
Initially, a register-based study from Taiwan suggested that the administration of DPP-4 inhibitors could be associated with an increased risk of TC (Tseng, 2016)